Hatteras Investment Partners, LP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 95 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Hatteras Investment Partners, LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q4 2016$305,000
-37.6%
5,471
-48.9%
1.78%
+6.2%
Q3 2016$489,000
-37.9%
10,705
-45.6%
1.68%
-61.9%
Q2 2016$787,000
+2.1%
19,695
-11.1%
4.40%
+108.8%
Q1 2016$771,000
-21.1%
22,150
-2.6%
2.11%
+64.9%
Q4 2015$977,00022,7401.28%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 285,259$16,685,0009.76%
JW Asset Management, LLC 73,649$4,308,0002.32%
THB ASSET MANAGEMENT 113,485$6,637,0000.81%
Eversept Partners, LP 21,900$1,280,9310.56%
EAM Global Investors LLC 20,642$1,207,0000.49%
RICE HALL JAMES & ASSOCIATES, LLC 181,690$10,627,0000.38%
Elk Creek Partners, LLC 114,230$6,681,0000.36%
ISTHMUS PARTNERS, LLC 19,525$1,142,0000.29%
PURA VIDA INVESTMENTS, LLC 20,160$1,179,0000.25%
CADENCE CAPITAL MANAGEMENT LLC 49,363$2,887,0000.16%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders